These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2845732)

  • 1. Calcitonin receptor binding as a marker of osteoclast heterogeneity in osteopetrotic rodents.
    Rouleau MF; Warshawsky H; Marks SC; Goltzman D
    J Bone Miner Res; 1986 Dec; 1(6):543-53. PubMed ID: 2845732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of bone and parathyroid hormone as stimulators of osteoclast development and activity in calvarial cell cultures from normal and osteopetrotic (mi/mi) mice.
    Graves L; Jilka RL
    J Cell Physiol; 1990 Oct; 145(1):102-9. PubMed ID: 2211836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin-induced change in serum calcium levels and its relationship to osteoclast morphology and number of calcitonin receptors.
    Ikegame M; Ejiri S; Ozawa H
    Bone; 2004 Jul; 35(1):27-33. PubMed ID: 15207738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal changes of osteoclasts in osteopetrosis (op/op) mice defective in production of functional macrophage colony-stimulating factor (M-CSF) protein and effects of M-CSF on osteoclast development and differentiation.
    Umeda S; Takahashi K; Naito M; Shultz LD; Takagi K
    J Submicrosc Cytol Pathol; 1996 Jan; 28(1):13-26. PubMed ID: 8929623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hematogenous origin of osteoclasts: experimental evidence from osteopetrotic (microphthalmic) mice treated with spleen cells from beige mouse donors.
    Marks SC; Walker DG
    Am J Anat; 1981 May; 161(1):1-10. PubMed ID: 6264778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological evidence of reduced bone resorption in the osteosclerotic (oc) mouse.
    Seifert MF; Marks SC
    Am J Anat; 1985 Feb; 172(2):141-53. PubMed ID: 3976544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of colony stimulating factor-1 gene expression in the skeleton of four osteopetrotic mutations in rats and mice.
    Shalhoub V; Jackson ME; Paradise C; Stein GS; Lian JB; Marks SC
    J Cell Physiol; 1996 Feb; 166(2):340-50. PubMed ID: 8591994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological evidence of reduced bone resorption in osteopetrotic (op) mice.
    Marks SC
    Am J Anat; 1982 Feb; 163(2):157-67. PubMed ID: 7072615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoclast biology in the osteopetrotic (op) rat.
    Marks SC; Popoff SN
    Am J Anat; 1989 Dec; 186(4):325-34. PubMed ID: 2589217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CSF-1 in bone and bone marrow development.
    Cecchini MG; Hofstetter W; Halasy J; Wetterwald A; Felix R
    Mol Reprod Dev; 1997 Jan; 46(1):75-83; discussion 83-4. PubMed ID: 8981367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the mechanism of spleen cell cure for osteopetrosis in ia rats: appearance of osteoclasts with ruffled borders.
    Marks SC
    Am J Anat; 1978 Jan; 151(1):119-29. PubMed ID: 623032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative roles of osteoclast colony-stimulating factor and macrophage colony-stimulating factor in the course of osteoclast development.
    Lee TH; Fevold KL; Muguruma Y; Lottsfeldt JL; Lee MY
    Exp Hematol; 1994 Jan; 22(1):66-73. PubMed ID: 8282061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of calcitonin receptors during osteoclast differentiation in mouse metatarsals.
    Taylor LM; Tertinegg I; Okuda A; Heersche JN
    J Bone Miner Res; 1989 Oct; 4(5):751-8. PubMed ID: 2554690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone remodeling and macrophage differentiation in osteopetrosis (op) mutant mice defective in the production of macrophage colony-stimulating factor.
    Takatsuka H; Umezu H; Hasegawa G; Usuda H; Ebe Y; Naito M; Shultz LD
    J Submicrosc Cytol Pathol; 1998 Apr; 30(2):239-47. PubMed ID: 9648288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformations of osteoclast phenotype in ia rats cured of congenital osteopetrosis.
    Marks SC; Schneider GB
    J Morphol; 1982 Nov; 174(2):141-7. PubMed ID: 7175944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced life span of the osteoclast in osteopetrotic (mi and midi) mice.
    Marshall MJ; Rees JA; Nisbet NW; Wiseman J
    Bone Miner; 1987 Apr; 2(2):115-24. PubMed ID: 3504723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of M-CSF and its receptor in microphthalmic mice.
    Yang S; Zhang Y; Ries WL; Key LL
    Exp Hematol; 1995 Feb; 23(2):126-32. PubMed ID: 7828669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice.
    Blin-Wakkach C; Breuil V; Quincey D; Bagnis C; Carle GF
    Bone; 2006 Jul; 39(1):53-60. PubMed ID: 16503212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human osteopetrosis and other sclerosing disorders: recent genetic developments.
    de Vernejoul MC; Bénichou O
    Calcif Tissue Int; 2001 Jul; 69(1):1-6. PubMed ID: 11685426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells.
    Yamashita T; Asano K; Takahashi N; Akatsu T; Udagawa N; Sasaki T; Martin TJ; Suda T
    J Cell Physiol; 1990 Dec; 145(3):587-95. PubMed ID: 1703173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.